DiagnosTear Ltd. – Recruitment of the first participant for clinical trial using the TeaRx ™ technology

The Company hereby announces that on August 31, 2017, DiagnosTear Ltd. (“DiagnosTear”) announced the recruitment of a first participant for an additional clinical trial to examine a product based on the TeaRx ™ technology, which is used to diagnose, personalize treatment and monitoring Dry eye syndrome by examining the composition …

Continue reading

Successful Feasibility Clinical Study Results for the Detection of Prostate Cancer with CellDetect Non-Invasive Test

BioLight announced on promising results from a feasibility clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect® technology. The study successfully demonstrated the feasibility of detecting intact cells originating in the prostate from urine samples following prostate massage.

Link to complete article

Continue reading

BioLight Reports 2015 Financial Results

BioLight Life Sciences reported operational and financial results for the year ended December 31, 2015.  Results were characterized by continued development and commercial progress in multiple markets, and the achievement of all previously announced 2015 milestones.

Operational Highlights:

  • Completed an upsized private investment and signed a strategic partnership with …

    Continue reading